Molecular epidemiology and antimicrobial resistance profiles of Pseudomonas aeruginosa causing bloodstream infections in neutropenic cancer patients

[Background:] Bloodstream infections (BSI) in neutropenic cancer patients, particularly those caused by Pseudomonas aeruginosa (PA), are associated with high morbidity and mortality. The increasing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) PA strains complicates cl...

ver descrição completa

Detalhes bibliográficos
Autores: Badía-Tejero, Ana M., Badía-Tejero, Ana María, López-Causapé, Carla, Morosini, María-Isabel, Portillo-Calderón, Inés, Machado, Marina, Larrosa, Nieves, Martín Dávila, Piluca, Palacios-Baena, Zaira Raquel, Puig-Albasanz, Adaia, Tubau, Fe, Oliver, Antonio, Sastre, Enric, Martí, Sara, Gudiol, Carlota
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/406063
Acesso em linha:http://hdl.handle.net/10261/406063
https://api.elsevier.com/content/abstract/scopus_id/105018939799
Access Level:acceso abierto
Palavra-chave:Pseudomonas aeruginosa
Bacteraemia
Bloodstream infection
Cancer
Multidrug resistance
Neutropenia
Virulence factors
Descrição
Resumo:[Background:] Bloodstream infections (BSI) in neutropenic cancer patients, particularly those caused by Pseudomonas aeruginosa (PA), are associated with high morbidity and mortality. The increasing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) PA strains complicates clinical management. This study aimed to characterise PA strains causing BSI in neutropenic cancer patients and assess the association between microbiological features and clinical outcomes.